BiotechTube
Home/Vitarka Therapeutics/Mayer Schreiber
MS

Mayer Schreiber

Investor Director

Vitarka Therapeutics

Therapeutic Areas

Oncology

Vitarka Therapeutics Pipeline

DrugIndicationPhase
EndoPore PlatformLate-stage cancersPre-clinical

Leadership Team at Vitarka Therapeutics

VT
Vineeta Tripathi
CEO
JB
John Beadle
Chairman
TH
Tim Hammonds
CSO
JF
Jim Faulkner
Non-Executive Director
AS
Agnes Szafranek
Head of R&D Operations
SC
Stephen Chambers
Board Observer
View full Vitarka Therapeutics profile